Edition:
United States

Aurobindo Pharma Ltd (ARBN.BO)

ARBN.BO on Bombay Stock Exchange

619.30INR
1:20am EDT
Change (% chg)

Rs-1.80 (-0.29%)
Prev Close
Rs621.10
Open
Rs621.90
Day's High
Rs622.55
Day's Low
Rs612.05
Volume
28,761
Avg. Vol
122,991
52-wk High
Rs838.00
52-wk Low
Rs566.00

About

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system,... (more)

Overall

Beta: 0.84
Market Cap(Mil.): Rs437,068.31
Shares Outstanding(Mil.): 585.88
Dividend: 1.25
Yield (%): 0.52

Financials

  ARBN.BO Industry Sector
P/E (TTM): 19.51 29.30 32.55
EPS (TTM): 38.23 -- --
ROI: -- 14.23 13.82
ROE: -- 15.46 15.24

Takeda unit sues Aurobindo to block generic Velcade

A U.S. unit of Japan's Takeda Pharmaceutical Co has sued generic drugmaker Aurobindo Pharma Ltd over its plans to make a cheaper version of Takeda's cancer drug Velcade.

Mar 07 2019

Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in the U.S.

A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration.

Jan 02 2019

Earnings vs. Estimates